Rooijakkers, Maxim J. P.
Versteeg, Geert A. A.
Hemelrijk, Kimberley I.
Aarts, Hugo M.
Overduin, Daniël C.
van Ginkel, Dirk-Jan
Vlaar, Pieter J.
van Wely, Marleen H.
van Nunen, Lokien X.
van Geuns, Robert Jan
van Garsse, Leen A. F. M.
Geuzebroek, Guillaume S. C.
Verkroost, Michel W. A.
Rodwell, Laura
Heijmen, Robin H.
Tonino, Pim A. L.
ten Berg, Jurrien M.
Delewi, Ronak
van Royen, Niels
Funding for this research was provided by:
Medtronic (A 1678426/SVZ)
Article History
Accepted: 8 March 2024
First Online: 23 April 2024
Conflict of interest
: M.H. van Wely has been a proctor and consultant for Abbott Vascular. R.H. Heijmen has been a consultant for Medtronic. P.A.L. Tonino and R. Delewi are Associate Editors of the Netherlands Heart Journal. N. van Royen has received research funding from Abbott, Philips, Medtronic and Biotronik, has served as a consultant for RainMed, Castor and Medtronic and has received speaker fees from Abbott and Bayer. M.J.P. Rooijakkers, G.A.A. Versteeg, K.I. Hemelrijk, H.M. Aarts, D.C. Overduin, D.-J. van Ginkel, P.J. Vlaar, , L.X. van Nunen, R.J. van Geuns, L.A.F.M. van Garsse, G.S.C. Geuzebroek, M.W.A. Verkroost, L. Rodwell and J.M. ten Berg declare that they have no competing interests.